GDF15 and atherosclerosis: The biomarkers that were used to estimate subclinical atherosclerosis in patients with psoriasis were serum myeloperoxidase, urinary orosomucoid, glycoprotein acetylation (GlycA), modified lipid oxidation, circulating growth differentiation factor-15 (GDF-15), and neutrophil-to-lymphocyte ratio (NLR) [35,48].